The NGSC in Dublin is Novartis’s leading digital science centre globally. This is due to the fact that there is such a large amount of digital talent and a significant tech ecosystem in Ireland... We have an innovative team of data scientists and data managers who are harnessing the power of digital to revolutionise the way that we manage disease and ultimately get our medicines to patients faster.
Head of Novartis Global Service Centre
Novartis
Headquartered in Basel, Switzerland, Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their goal is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in Research & Development and novel access approaches.About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. In 2022, net sales from continuing operations were $50.5 billion.
One of the first pharmaceutical companies to locate in Ireland in the 1950’s, Novartis has a strong history of investing in Ireland over the last sixty years.
Novartis currently employs approximately 1000 people in Dublin. In March 2013, Novartis announced the establishment of the Novartis Corporate Center in Elm Park, Dublin. Novartis Commercial Operations is also based in Elm Park. Novartis’ nationwide presence, and flexible working options, means there are Novartis employees based all over Ireland.
Longstanding Irish presence
Novartis’ presence in Ireland dates back to the 1950s, when it was one of the first multinational pharmaceutical companies to set up in the country. In 1994, Novartis Ringaskiddy Limited, based in county Cork, was set up to manufacture active pharmaceutical ingredients (APIs) for a range of medicines. In 2022, Novartis announced it had reached an agreement with Sterling Pharma Solutions, a leading global development and manufacturing company, to transfer the Ringaskiddy site to Sterling. Going forward Sterling Pharma Solutions are producing Novartis APIs for cardiology, immunology and oncology medicines in Ireland.Continuing commitment to Ireland
Novartis’ Corporate Centre in Dublin, is one six around the world, which deliver a variety of services to Novartis globally. The Center delivers high quality commercial, medical and clinical business solutions, leveraging the significant life science and tech eco-system in Ireland. Geographically positioned between the Novartis Headquarters in Switzerland and the US, the Corporate Center's Dublin location enables a deep partnering and understanding of key customer business problems, from an English-speaking corporate base.How Ireland Helps Novartis
- Company presence in Ireland dating back more than 70 years
- Approximately 1,000 people employed at Novartis in Ireland
- Workforce in Ireland comprises >40 nationalities speaking 29 languages
- Almost half of Novartis associates hold master’s degrees while 17% hold a PhD
Novartis has a strong history of investing in Ireland over the last sixty years
Almost half of Novartis associates hold master’s degrees while 17% hold a PhD.
Workforce in Ireland comprises >40 nationalities speaking 29 languages.
You Might Also Be Interested In
BioMarin Announces Significant Investment and Expansion of Cork Facility
BioMarin Pharmaceutical Inc. announced a €60 million investment in the expansion of its state-of-the-art facility in Shanbally, Co. Cork., with addition of a new, four-story laboratory facility that will enable the company to increase production capacity for currently approved medicines and create room for future growth.
Read more
Hovione Almost Doubles Spray Drying Capacity With Multi-Million Euro Investment In Cork, Ireland
Hovione, an international pharmaceutical contract development and manufacturing organisation (CDMO), today officially commissioned an expansion at its manufacturing facility in Ringaskiddy, Co. Cork.
Read more